跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LK-3
首页
药物
LK-3
LK-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DRUG-PROTEIN CONJUGATES
申请人: POLYTHERICS LTD
优先权: 2012
EP
AMHRII-BINDING ANTIBODY DRUG CONJUGATES AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS
申请人: GAMAMABS PHARMA
优先权: 2019
EP
一种虫草素-抗菌肽偶合物及其合成方法和应用
申请人: 红河学院
优先权: 2023
CN
Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
申请人: OREAL D I P I L
优先权: 2004
EP
Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
申请人: OREAL
优先权: 2004
EP
Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
申请人: OREAL
优先权: 2004
EP
一种降解靶蛋白的双功能化合物及其用途
申请人: 泰比瑞医药科技(石家庄)有限公司
优先权: 2020
CN
Compound as well as synthesis method and application thereof
申请人: UNIV HONGHE
优先权: 2023
CN
2 件公开
药物
反馈